|
BRD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.775200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.411500E-04 |
| Normal-vs-Stage2 |
6.736900E-03 |
| Normal-vs-Stage3 |
8.444300E-04 |
| Normal-vs-Stage4 |
7.564500E-03 |
| Stage1-vs-Stage2 |
5.879600E-01 |
| Stage1-vs-Stage3 |
3.872400E-01 |
| Stage1-vs-Stage4 |
7.692000E-01 |
| Stage2-vs-Stage3 |
9.349000E-01 |
| Stage2-vs-Stage4 |
8.509400E-01 |
| Stage3-vs-Stage4 |
7.550400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.561600E-04 |
| Normal-vs-AfricanAmerican |
8.958400E-02 |
| Normal-vs-Asian |
1.801650E-01 |
| Caucasian-vs-AfricanAmerican |
5.514600E-01 |
| Caucasian-vs-Asian |
9.619900E-02 |
| AfricanAmerican-vs-Asian |
5.081000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.560300E-02 |
| Normal-vs-Female |
8.4228000000075E-05 |
| Male-vs-Female |
8.180300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.079870E-03 |
| Normal-vs-Age(41-60Yrs) |
1.742960E-03 |
| Normal-vs-Age(61-80Yrs) |
1.318640E-03 |
| Normal-vs-Age(81-100Yrs) |
4.519400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.996200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.233800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.320400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.529200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.942400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.974800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.822800E-03 |
| Classical-VS-Follicular |
8.422000E-04 |
| Classical-VS-Other |
7.684000E-01 |
| Classical-VS-Normal |
1.590160E-02 |
| Tall-VS-Follicular |
6.339400E-01 |
| Tall-VS-Other |
2.007600E-01 |
| Tall-VS-Normal |
5.60569999999982E-05 |
| Follicular-VS-Other |
4.122200E-01 |
| Follicular-VS-Normal |
4.08069999999761E-05 |
| Other-VS-Normal |
2.472800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.964300E-04 |
| Normal-vs-N1 |
3.138400E-02 |
| N0-vs-N1 |
5.187200E-01 |
|
|
